1. Background: uBiome was one of the top five incubations that emerged from the Bay Area. During its first year, the company raised $83 million, and as of January this … Continue Reading After Raid uBiome Files for Bankruptcy
At the young age of 34, Vivek Ramaswamy, the CEO of Roivant Sciences, has a net worth of a staggering $600 million! Graduating from Harvard with a degree in biology, … Continue Reading Biotech Investor Turned Entrepreneur is $3 Billion Richer
Beta-amyloid plaques, which are clusters of proteins found in the brains of Alzheimer’s patients, can damage neurons and compromise brain functions.
Introduction Studies being conducted at Texas University, MD Anderson Cancer Center, revealed that there is a high distinctiveness between the pancreatic cancer patients who survive for the long term and … Continue Reading Pancreatic Cancer Survival Linked To Tumor Microbiome
Transgene (TNG: FP), a French biotechnology company with the ambitious goal of taking oncolytic viruses to the market is facing a significant hurdle. A clinical trial reviewed by an independent … Continue Reading Transgene Stops Phase III Clinical Trial Deemed Useless
Assistant Professor Nick Graham of Chemical Engineering and Materials Science has been studying the process of aging with his team. He has made several discoveries that can be helpful in … Continue Reading USC Scientists Tap into Aging with Senescent Cells
At first, you need to have a little introduction to these two companies. They both are pharmaceuticals. They provide medicines and research related to medicine. What are they and what … Continue Reading Mallinckrodt and Silence Therapeutics Partner up for RNAi
Early Success for Hemophilia Gene Therapy Diseases that are genetically inherited are a little tricky to deal with. Since they don’t manifest themselves early on and have the potential to … Continue Reading Gene Therapy for Hemophilia has Early Success